These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12519076)
1. Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells. Olsen J; Kirkeby LT; Brorsson MM; Dabelsteen S; Troelsen JT; Bordoy R; Fenger K; Larsson LI; Simon-Assmann P Biochem J; 2003 Apr; 371(Pt 1):211-21. PubMed ID: 12519076 [TBL] [Abstract][Full Text] [Related]
2. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. RodrÃguez-Pascual F; Redondo-Horcajo M; Lamas S Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024 [TBL] [Abstract][Full Text] [Related]
3. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872 [TBL] [Abstract][Full Text] [Related]
4. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J; Dai C; Liu Y J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870 [TBL] [Abstract][Full Text] [Related]
5. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Fink SP; Mikkola D; Willson JK; Markowitz S Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756 [TBL] [Abstract][Full Text] [Related]
8. Involvement of activator protein 1 complexes in the epithelium-specific activation of the laminin gamma2-chain gene promoter by hepatocyte growth factor (scatter factor). Olsen J; Lefebvre O; Fritsch C; Troelsen JT; Orian-Rousseau V; Kedinger M; Simon-Assmann P Biochem J; 2000 Apr; 347(Pt 2):407-17. PubMed ID: 10749670 [TBL] [Abstract][Full Text] [Related]
9. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related]
10. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Levy L; Hill CS Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802 [TBL] [Abstract][Full Text] [Related]
11. Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements. Kantola AK; Keski-Oja J; Koli K Gene; 2005 Dec; 363():142-50. PubMed ID: 16223572 [TBL] [Abstract][Full Text] [Related]
12. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Schiller M; Verrecchia F; Mauviel A Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784 [TBL] [Abstract][Full Text] [Related]
14. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Tobon A; Varani J; Brattain MG Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738 [TBL] [Abstract][Full Text] [Related]
15. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Chou YT; Wang H; Chen Y; Danielpour D; Yang YC Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Pendaries V; Verrecchia F; Michel S; Mauviel A Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262 [TBL] [Abstract][Full Text] [Related]
17. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]